Published in J Am Soc Nephrol on March 12, 2008
Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant (2013) 0.86
Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development. Pediatr Rheumatol Online J (2008) 0.83
Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysis. Pharmaceuticals (Basel) (2013) 0.79
The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors. Arab J Urol (2012) 0.75
Factors affecting graft survival among patients receiving kidneys from live donors: a single-center experience. Biomed Res Int (2013) 0.75
Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients. Transplant Direct (2016) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation (1999) 2.81
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Transplantation (2007) 1.80
Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. Transplantation (2002) 1.52
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45
Cyclosporine nephrotoxicity. Kidney Int (1986) 1.44
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation (2002) 1.33
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33
Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation (2002) 1.26
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation (2002) 1.25
Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation. Transplantation (2001) 0.94
Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis (1989) 0.90
Histopathological findings in well-functioning, long-term renal allografts. Kidney Int (1992) 0.89
Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function. Transplantation (1998) 0.85
Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols. Nephrol Dial Transplant (2007) 0.84
Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients. Transplant Proc (2000) 0.84
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. Transplantation (2004) 0.84
Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. Am J Transplant (2005) 0.84
Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation. Transplantation (2006) 0.83
Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients. Transplantation (2000) 0.81
Cyclosporine-induced renal dysfunction: correlations between cellular events and whole kidney function. J Am Soc Nephrol (1991) 0.80
Tuberculosis in Egyptian kidney transplant recipients: study of clinical course and outcome. J Nephrol (2003) 0.80
Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report. Transplantation (1998) 0.79
Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol (2011) 1.64
A prospective randomized study for prevention of postrenal transplantation bone loss. Kidney Int (2005) 1.49
Serous-lined unidirectional valve for construction of continent cutaneous urinary reservoir: the test of time. Urology (2012) 1.44
Catheterizable serous lined urinary outlet in children and adolescents: a choice when other treatments fail. J Urol (2011) 1.39
Magnetic resonance imaging as a sole method for the morphological and functional evaluation of live kidney donors. BJU Int (2005) 1.38
End-stage renal disease among living-kidney donors: single-center experience. Exp Clin Transplant (2011) 1.25
Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study--a single center experience. J Urol (2004) 1.16
Neural network-based assessment of prognostic markers and outcome prediction in bilharziasis-associated bladder cancer. IEEE Trans Inf Technol Biomed (2003) 1.08
Multiple arteries in live donor renal transplantation: surgical aspects and outcomes. J Urol (2003) 1.05
Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience. Pediatr Transplant (2005) 1.03
Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol (2004) 1.02
Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis. Cancer Res (2008) 1.01
Prediction of survival after radical cystectomy for invasive bladder carcinoma: risk group stratification, nomograms or artificial neural networks? J Urol (2009) 1.01
Critical evaluation of the problem of chronic urinary retention after orthotopic bladder substitution in women. J Urol (2002) 1.00
Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice. Cell Transplant (2012) 0.98
Vascular complications after live donor renal transplantation: study of risk factors and effects on graft and patient survival. J Urol (2003) 0.98
Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation (2004) 0.97
Robot-assisted radical cystectomy and urinary diversion in female patients: technique with preservation of the uterus and vagina. J Am Coll Surg (2004) 0.96
Bridging long ureteral defects using the Yang-Monti principle. J Urol (2003) 0.94
Bladder carcinoma among live-donor renal transplant recipients: a single-centre experience and a review of the literature. BJU Int (2007) 0.91
Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res (2005) 0.91
A prospective, randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients: ten-year follow-up. Transplantation (2004) 0.91
Effect of donor/recipient body weight mismatch on patient and graft outcome in living-donor kidney transplantation. Am J Nephrol (2003) 0.91
Transplantation of insulin-producing clusters derived from adult bone marrow stem cells to treat diabetes in rats. Exp Clin Transplant (2008) 0.90
Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely? J Urol (2004) 0.90
Long-term follow-up of living kidney donors: a longitudinal study. BJU Int (2007) 0.89
Bilateral Wilms' tumors: single-center experience with 22 cases and literature review. Urology (2010) 0.88
Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation. Pediatr Transplant (2004) 0.88
Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges. J Nucleic Acids (2013) 0.88
Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course. Nephron Clin Pract (2005) 0.88
An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl Int (2007) 0.87
Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients. Am J Nephrol (2003) 0.87
Pediatric live-donor kidney transplantation in Mansoura Urology & Nephrology Center: a 28-year perspective. Pediatr Nephrol (2006) 0.87
Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer. J Urol (2006) 0.85
Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. Am J Transplant (2005) 0.84
Perineal anastomotic urethroplasty for managing post-traumatic urethral strictures in children: the long-term outcome. BJU Int (2005) 0.84
Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial. J Nephrol (2003) 0.84
Prevention of Transnational Transplant-Related Crimes-What More Can be Done? Transplantation (2016) 0.82
Evaluation and selection of potential live kidney donors. J Urol (2004) 0.82
Treatment of osteopenia and osteoporosis in renal transplant children and adolescents. Pediatr Transplant (2004) 0.81
Death with functioning graft in living donor kidney transplantation: analysis of risk factors. Am J Nephrol (2003) 0.81
Can intravenous immunoglobulin and simvastatin solve the problem of sensitization in renal transplant candidates? Int Urol Nephrol (2007) 0.81
Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience. Clin Exp Nephrol (2009) 0.81
The health of elderly living kidney donors after donation. Ann Transplant (2009) 0.81
Neurophysiologic changes in live related kidney transplant children and adolescents. Pediatr Transplant (2005) 0.81
Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: a five-year prospective randomized study. Am J Nephrol (2005) 0.81
Tuberculosis in Egyptian kidney transplant recipients: study of clinical course and outcome. J Nephrol (2003) 0.80
Surgical complications following radical cystectomy and orthotopic neobladders in women. J Urol (2008) 0.80
Basiliximab induction therapy for live donor kidney transplantation: a long-term follow-up of prospective randomized controlled study. Clin Exp Nephrol (2008) 0.80
Musculoskeletal affections among kidney recipients: prevalence and risk predictors. Rheumatol Int (2008) 0.79
Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience. Clin Exp Nephrol (2007) 0.79
Clinical features and course of Kaposi's sarcoma in Egyptian kidney transplant recipients. Am J Transplant (2003) 0.79
Growth in children with chronic renal failure and after renal transplantation. Int Urol Nephrol (2007) 0.79
Preventing bone loss in renal transplant recipients with vitamin D. J Am Soc Nephrol (2003) 0.79
2D and 3D shape based segmentation using deformable models. Med Image Comput Comput Assist Interv (2005) 0.79
Hemolytic anemia after ABO nonidentical living donor kidney transplantation. Clin Exp Nephrol (2009) 0.79
Complete repair of exstrophy: further experience with neonates and children after failed initial closure. J Urol (2002) 0.78
Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study. Scand J Urol Nephrol (2010) 0.78
Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations? Exp Clin Transplant (2008) 0.78
Characteristics of recipients whose kidney allograft has functioned for more than 20 years. Exp Clin Transplant (2008) 0.78
A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents. Am J Transplant (2004) 0.78
Postkidney transplant malignancy in Egypt has a unique pattern: a three-decade experience. Transplantation (2008) 0.77
Living-donor kidney retransplantation: risk factors and outcome. BJU Int (2004) 0.77
Preemptive living-donor kidney transplantation: clinical course and outcome. Transplantation (2004) 0.77
Ten-year follow-up of basiliximab induction therapy for live-donor kidney transplant: a prospective randomized controlled study. Exp Clin Transplant (2011) 0.77
Nail changes in kidney transplant recipients. Nephrol Dial Transplant (2009) 0.77
Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant. Exp Clin Transplant (2011) 0.77
Surgical analysis of pediatric and adolescent sporadic pheochromocytoma: single center experience. Int Urol Nephrol (2011) 0.77
Complications of pediatric live-donor kidney transplantation: a single center's experience in Egypt. Pediatr Nephrol (2007) 0.77
Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Iran J Kidney Dis (2008) 0.77
Glutathione peroxidase activity in patients with renal disorders. Clin Exp Nephrol (2005) 0.77
Hepatic dysfunction in kidney transplant recipients: prevalence and impact on graft and patient survival. Clin Exp Nephrol (2007) 0.76
Serotyping of hepatitis C virus in hemodialysis patients: comparison with a standardized genotyping assay. Diagn Microbiol Infect Dis (2005) 0.76
Power doppler sonography in early renal transplantation: does it differentiate acute graft rejection from acute tubular necrosis? Saudi J Kidney Dis Transpl (2014) 0.76
Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience. Saudi J Kidney Dis Transpl (2008) 0.76
Bone mineral density in live related kidney transplant children and adolescents. Int Urol Nephrol (2004) 0.75
Factors affecting graft survival among patients receiving kidneys from live donors: a single-center experience. Biomed Res Int (2013) 0.75
Impact of posterior urethral valves on pediatric renal transplantation: a single-center comparative study of 297 cases. Pediatr Transplant (2011) 0.75
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
Pretransplant mixed lymphocyte culture still has an impact on graft survival. Am J Nephrol (2004) 0.75
Characteristics of long-term live-donor renal allograft survivors. Am J Nephrol (2003) 0.75
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
Scattered radiation effects on the extrinsic sensitivity and counting efficiency of a gamma camera. Appl Radiat Isot (2013) 0.75
Characteristics of patients with Banff borderline changes in renal allograft biopsies. Exp Clin Transplant (2009) 0.75
Association and prognostic impact of persistent left ventricular hypertrophy after live-donor kidney transplantation: a prospective study. Clin Exp Nephrol (2009) 0.75
A 2-year follow-up after rotoresection of the prostate: a prospective study. BJU Int (2005) 0.75
Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up. Int Urol Nephrol (2007) 0.75
Gene and stem cell therapy for diabetes. Clin Transpl (2013) 0.75
Osteonecrosis in kidney recipients: has hypocalcaemia a role? Rheumatol Int (2009) 0.75
Retropubic bulbourethral sling in incontinence post-exstrophy repair: 2-year minimal follow up of a salvage procedure. Neurourol Urodyn (2015) 0.75